We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

MindMate: A Study of a Reminder System for People With Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02908997
Recruitment Status : Completed
First Posted : September 21, 2016
Last Update Posted : November 6, 2018
Sponsor:
Collaborator:
University of Glasgow
Information provided by (Responsible Party):
NHS Greater Glasgow and Clyde

Brief Summary:
A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia

Condition or disease Intervention/treatment Phase
Dementia Other: MindMate Not Applicable

Detailed Description:

Background

Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.

Aims

This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.

Method

Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.

Applications

This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: MindMate: A Single Case Experimental Design Study of a Reminder System for People With Mild Dementia
Actual Study Start Date : January 17, 2017
Actual Primary Completion Date : July 31, 2018
Actual Study Completion Date : July 31, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dementia

Arm Intervention/treatment
Experimental: 5 week baseline
5 week baseline data collection followed by 6 week MindMate intervention
Other: MindMate
A dementia-specific mobile reminding application

Experimental: 6 week baseline
6 week baseline data collection followed by 6 week MindMate intervention
Other: MindMate
A dementia-specific mobile reminding application

Experimental: 7 week baseline
7 week baseline data collection followed by 6 week MindMate intervention
Other: MindMate
A dementia-specific mobile reminding application




Primary Outcome Measures :
  1. Memory [ Time Frame: 6 weeks ]
    Number of target events the participant remembered to complete


Secondary Outcome Measures :
  1. Acceptability [ Time Frame: Change from baseline to 6 week post-intervention ]
    Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • has a diagnosis of Mild Dementia, according to International Classification of Diseases (ICD) 10 Criteria
  • has received the diagnosis from a psychiatrist
  • owns a smart phone or tablet
  • has a family member/partner/carer who is willing to monitor memory aid use
  • has capacity to consent to being involved in the research
  • is reporting memory difficulties that are affecting them in daily life

Exclusion Criteria:

  • visual or auditory difficulties which cannot be corrected through the use of appropriate aids
  • has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)
  • has a diagnosis of dementia that is considered to be in the moderate to severe stages
  • those whose first language is not English
  • those with a diagnosed or suspected developmental learning disability
  • those who are currently using online or electronic memory aids

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02908997


Locations
Layout table for location information
United Kingdom
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
Sponsors and Collaborators
NHS Greater Glasgow and Clyde
University of Glasgow
Investigators
Layout table for investigator information
Principal Investigator: Jonathan Evans, BSc DClinPsy PhD University of Glasgow
Layout table for additonal information
Responsible Party: NHS Greater Glasgow and Clyde
ClinicalTrials.gov Identifier: NCT02908997    
Other Study ID Numbers: GN16NE538
First Posted: September 21, 2016    Key Record Dates
Last Update Posted: November 6, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders